This search combines search strings from the content search (i.e. "Full Text", "Author", "Title", "Abstract", or "Keywords") with "Article Type" and "Publication Date Range" using the AND operator.
Beilstein J. Org. Chem. 2014, 10, 1967–1980, doi:10.3762/bjoc.10.205
Graphical Abstract
Figure 1: Examples of biologically active acyclic and cyclic nucleotide analogs.
Figure 2: The pyrrolidine nucleotide analogs investigated in this study.
Scheme 1: The synthesis of pyrrolidine nucleotides 7–14.
Figure 3: The numbering of the pyrrolidine ring, the nucleobase and the endocyclic phase angles for the purpo...
Figure 4: The aliphatic part (pyrrolidine protons) of the 1H NMR spectra of 9 measured in D2O at different pD...
Figure 5: Changes of selected 1H and 13C chemical shifts of 9 upon pD change.
Figure 6: The deuteration equilibria of phosphonomethyl derivatives 7–10.
Figure 7: The aliphatic part (pyrrolidine protons) of the 1H NMR spectra of 13 measured in D2O at different p...
Figure 8: Amide rotamers of phosphonoformyl derivatives 11–14.
Figure 9: The 31P NMR spectra (202.3 MHz) of 14 measured (the black curve) and simulated (the red curve) at v...
Figure 10: A part of the H,C-HSQC spectrum of derivative 13, showing the assignment of rotamers A and B.
Figure 11: The pseudorotation pathway of the pyrrolidine ring in the compounds studied. The sign B stands for ...
Figure 12: An example of the stereospecific assignment of pyrrolidine-ring protons of 14 in the H,H-ROESY spec...
Figure 13: The energy profile of the five-membered pyrrolidine ring pseudorotation for adenine derivatives 9 a...
Figure 14: The most stable conformations of adenine derivatives 9 and 13A calculated by the B3LYP/6-31++G* met...